American Society for Transplantation and Cellular Therapy Pharmacy Special Interest Group Position Statement on Pharmacy Practice Management and Clinical Management for COVID-19 in Hematopoietic Cell Transplantation and Cellular Therapy Patients in the United States

The coronavirus-19 (COVID-19) pandemic poses a significant risk to patients undergoing hematopoietic stem cell transplantation (HCT) or cellular therapy. The American Society for Transplantation and Cellular Therapy Pharmacy Special Interest Group Steering Committee aims to provide pharmacy practice...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahmoudjafari, Zahra, Alexander, Maurice, Roddy, Julianna, Shaw, Ryan, Shigle, Terri Lynn, Timlin, Colleen, Culos, Katie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. 2020
Materias:
Position Statement
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7162779/
https://www.ncbi.nlm.nih.gov/pubmed/32305359
http://dx.doi.org/10.1016/j.bbmt.2020.04.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7162779/
https://www.ncbi.nlm.nih.gov/pubmed/32305359
http://dx.doi.org/10.1016/j.bbmt.2020.04.005

Ejemplares similares